fashion -WSS

fashion

author：entertainment 2025-08-23 08:57:50 - browse：6791

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： RaDonda Vaught case: a double standard for nurses, physicians

WSS

Structure Therapeutics oral GLP

FDA approves Moderna’s RSV vaccine, its second licensed product

For pregnant people, addiction treatment shouldn't mean a call to child protective services

PhRMA sues HHS over Medicare drug price negotiation

Illumina board agrees to spin off Grail, as divestment plans proceed

An outdated Medicare rule harms dementia patients with anxiety

entertainment

fashion

focus

Anesthesiologist group: stop taking Ozempic before surgery

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Activists slam private health insurers over coverage restrictions

For pregnant people, addiction treatment shouldn't mean a call to child protective services

State Dept. review finds Biden bears some blame for Afghanistan failures

Data don't support strong claims for Covid

Trump demands the U.S. pay no more for drugs than other countries … again

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Malaria cases in Florida and Texas: Here’s what you need to know

The most pressing bird flu mysteries scientists want answered

knowledge

Community addresses injustice for Long Island mothers

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Take antibiotics after sex, CDC recommends for certain risk groups

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

CMS got Medicare Advantage quality rating wrong, judge rules

Structure Therapeutics oral GLP

entertainment

focus

knowledge

hotspot